| Literature DB >> 31096242 |
Ajay Niranjan1, Edward Monaco2, John Flickinger3, L Dade Lunsford2.
Abstract
Stereotactic radiosurgery (SRS) is an effective treatment for patients with multiple brain metastases. Three decades of increasingly powerful scientific studies have shown that SRS improves outcomes and reduces toxicity when it replaces whole-brain radiation therapy (WBRT). Expert opinion surveys of clinicians have reported that the total intracranial tumor volume rather than the number of brain metastases is related to outcomes. As a result, an increasing number of treating and referring physicians have replaced the reflex use of WBRT with SRS, unless the patient has miliary disease or carcinomatous meningitis. In the current era of immunotherapy and targeted therapies with potentially increased systemic disease survival, 10 or more tumors are routinely treated with SRS alone at most academic medical centers. In a single SRS session we routinely treat patients with cumulative tumor volumes of 25 cm3 even if they have ≥10 metastases.Entities:
Mesh:
Year: 2019 PMID: 31096242 DOI: 10.1159/000493055
Source DB: PubMed Journal: Prog Neurol Surg ISSN: 0079-6492